99 related articles for article (PubMed ID: 2159251)
1. Tumor necrosis factor and hypermetabolism.
Seaton TB; Coombe N; Mittelman A
Ann Intern Med; 1990 May; 112(9):715-6. PubMed ID: 2159251
[No Abstract] [Full Text] [Related]
2. Novel radiotherapy schedules aid recovery of normal tissues after treatment.
Fowler JF
J Gastrointestin Liver Dis; 2010 Mar; 19(1):7-8. PubMed ID: 20361066
[No Abstract] [Full Text] [Related]
3. Prognostic and Therapeutic Values of Tumor Necrosis Factor-Alpha in Hepatocellular Carcinoma.
Wang H; Liu J; Hu X; Liu S; He B
Med Sci Monit; 2016 Oct; 22():3694-3704. PubMed ID: 27739418
[TBL] [Abstract][Full Text] [Related]
4. Aromatase inhibitors may be effective in the management of advanced hepatocellular carcinoma.
Altundag O; Altundag K; Turen S; Gunduz E; Atik MA
Med Hypotheses; 2006; 66(6):1257. PubMed ID: 16154711
[No Abstract] [Full Text] [Related]
5. Down-regulation of metallothionein expression in human and murine hepatocellular tumors: association with the tumor-necrotizing and antineoplastic effects of cadmium in mice.
Waalkes MP; Diwan BA; Rehm S; Ward JM; Moussa M; Cherian MG; Goyer RA
J Pharmacol Exp Ther; 1996 May; 277(2):1026-33. PubMed ID: 8627513
[TBL] [Abstract][Full Text] [Related]
6. [The effect and pharmacokinetics of etoposide in patients with primary hepatocellular carcinoma].
Funakoshi S; Aiba K; Dobashi F; Inamoto Y; Hirano A; Tada N; Ogihara A; Fujii T; Kuraishi Y; Yamada T
Gan To Kagaku Ryoho; 1993 Jan; 20(1):165-7. PubMed ID: 8380686
[No Abstract] [Full Text] [Related]
7. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065
[TBL] [Abstract][Full Text] [Related]
8. [Endothelin-secreting tumors].
Kohno M
Nihon Rinsho; 2004 Sep; 62 Suppl 9():668-72. PubMed ID: 15506471
[No Abstract] [Full Text] [Related]
9. Hepatocellular carcinoma: genome-scale metabolic models for hepatocellular carcinoma.
Pinyol R; Llovet JM
Nat Rev Gastroenterol Hepatol; 2014 Jun; 11(6):336-7. PubMed ID: 24840704
[TBL] [Abstract][Full Text] [Related]
10. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M
Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine.
Wang XN; Han X; Xu LN; Yin LH; Xu YW; Qi Y; Peng JY
Phytomedicine; 2008 Dec; 15(12):1062-8. PubMed ID: 18579357
[TBL] [Abstract][Full Text] [Related]
12. Re: Liu et al.--Estrogen receptor status in inoperable hepatocellular carcinoma.
Chow PK; Hung H; Soo KC
Am J Gastroenterol; 2001 Apr; 96(4):1297-8. PubMed ID: 11316190
[No Abstract] [Full Text] [Related]
13. Efficacy of sorafenib, molecular targeting drug, for advanced hepatocellular carcinoma.
Kuzuya T; Tsuchiya K; Izumi N
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1883-86. PubMed ID: 21069944
[No Abstract] [Full Text] [Related]
14. The role of somatostatin analogs in the management of hepatocellular carcinoma.
D'Agostino L; Manguso F; Pivonello R; Colao A
J Endocrinol Invest; 2003; 26(8 Suppl):131-3. PubMed ID: 15233229
[No Abstract] [Full Text] [Related]
15. The emerging antineoplastic effects of paeoniflorin.
Kapoor S
Anticancer Drugs; 2013 Apr; 24(4):429. PubMed ID: 23449475
[No Abstract] [Full Text] [Related]
16. Can metallothionein be a useful molecular marker for selecting hepatocellular carcinoma patients for platinum-based chemotherapy?
Doki Y; Monden M
J Gastroenterol; 2004 Dec; 39(12):1228-9. PubMed ID: 15622495
[No Abstract] [Full Text] [Related]
17. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway.
Mao J; Wang D; Wang Z; Tian W; Li X; Duan J; Wang Y; Yang H; You L; Cheng Y; Bian J; Chen Z; Yang Y
Cancer Lett; 2016 Sep; 380(1):134-43. PubMed ID: 27349166
[TBL] [Abstract][Full Text] [Related]
18. [Intra-arterial chemotherapy of primary hepatoma and changes in -fetoprotein levels].
Miura T; Sugimura M; Ishida M; Endo Y; Oda T
Nihon Rinsho; 1972 May; 30(5):1201-8. PubMed ID: 4339908
[No Abstract] [Full Text] [Related]
19. Successful targeted therapies for hepatocellular carcinoma: are we really getting there?
Zhu AX
Expert Rev Anticancer Ther; 2008 Apr; 8(4):499-505. PubMed ID: 18402516
[No Abstract] [Full Text] [Related]
20. A new TRAIL to therapy of hepatocellular carcinoma: blocking the proteasome.
Anan A; Gores GJ
Hepatology; 2005 Sep; 42(3):527-9. PubMed ID: 16116625
[No Abstract] [Full Text] [Related]
[Next] [New Search]
